Skip to main content
Equibles

Nirav Jhaveri

CFO

Opus Genetics, Inc. (IRD)

Equibles does not estimate personal net worth.

Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.

Get IRD alerts

About Nirav Jhaveri

Nirav Jhaveri is recorded as CFO at Opus Genetics, Inc. (IRD) since February 12, 2024. Opus Genetics, Inc. reported in an 8-K filed June 25, 2025 that Nirav Jhaveri was terminated as Chief Financial Officer, effective June 25, 2025. Opus Genetics, Inc. reported in an 8-K filed February 16, 2024 that Nirav Jhaveri was appointed Chief Financial Officer, effective February 14, 2024. Opus Genetics, Inc. reported in an 8-K filed February 16, 2024 that Nirav Jhaveri was appointed Chief Financial Officer, effective February 12, 2024. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.

“On June 25, 2025, Nirav Jhaveri, the Chief Financial Officer of Opus Genetics, Inc., a Delaware corporation (the "Company"), departed from the Company.”
Opus Genetics, Inc. Form 8-K, filed June 25, 2025 · Read the filing
“Ocuphire Pharma, Inc. (Nasdaq: OCUP) ("Ocuphire"), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced the appointments of Ash Jayagopal, Ph.D., M.B.A. as Chief Scientific and Development Officer, and Nirav Jhaveri, C.F.A., M.B.A. as Chief Financial Officer, effective today.”
Opus Genetics, Inc. Form 8-K, filed February 16, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Opus Genetics, Inc.

Recent activity